Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-06 11:00 am Purchase | 2026-03-31 | 13G | BIO-TECHNE CORP COM TECH | FMR LLC | 7,859,928 5.000% | 5,720,548 (+267.39%) | Filing History |
| 2026-04-29 5:00 pm Purchase | 2026-03-31 | 13G | BIO-TECHNE CORP COM TECH | VANGUARD CAPITAL MANAGEMENT LLC | 11,559,571 7.380% | 11,559,571 (New Position) | Filing History |
| 2026-03-26 4:10 pm Sale | 2026-03-13 | 13G | BIO-TECHNE CORP COM TECH | VANGUARD GROUP INC | 0 0.000% | -18,228,210 (Position Closed) | Filing History |
| 2025-11-14 12:19 pm Sale | 2025-09-30 | 13G | BIO-TECHNE CORP COM TECH | T. Rowe Price Associates, Inc. | 3,350,818 2.200% | -5,497,332 (-62.13%) | Filing History |
| 2025-08-14 1:07 pm Sale | 2025-06-30 | 13G | BIO-TECHNE CORP COM TECH | T. Rowe Price Associates, Inc. | 8,848,150 5.600% | -2,535,457 (-22.27%) | Filing History |
| 2025-07-16 7:02 pm Sale | 2025-06-30 | 13G | BIO-TECHNE CORP COM TECH | BlackRock Inc. BLK | 11,011,556 7.000% | -2,831,725 (-20.46%) | Filing History |
| 2025-05-14 10:45 am Purchase | 2025-03-31 | 13G | BIO-TECHNE CORP COM TECH | T. Rowe Price Associates, Inc. | 11,383,607 7.200% | 1,959,294 (+20.79%) | Filing History |
| 2024-11-14 1:22 pm Purchase | 2024-09-30 | 13G | BIO-TECHNE CORP COM TECH | T. Rowe Price Associates, Inc. | 9,424,313 5.900% | 9,424,313 (New Position) | Filing History |
| 2024-11-08 5:31 pm Unchanged | 2024-09-30 | 13G | BIO-TECHNE CORP COM TECH | BlackRock Inc. BLK | 13,843,281 8.700% | 0 (Unchanged) | Filing History |
| 2024-10-21 4:11 pm Sale | 2024-09-30 | 13G | BIO-TECHNE CORP COM TECH | BlackRock Inc. BLK | 13,843,281 8.700% | -4,290,631 (-23.66%) | Filing History |
| 2024-02-13 5:00 pm Purchase | 2023-12-29 | 13G | BIO-TECHNE CORP COM TECH | VANGUARD GROUP INC | 18,228,210 11.530% | 28,778 (+0.16%) | Filing History |
| 2024-01-24 09:46 am Purchase | 2023-12-31 | 13G | BIO-TECHNE CORP COM TECH | BlackRock Inc. BLK | 18,133,912 11.500% | 2,245,272 (+14.13%) | Filing History |
| 2023-02-09 11:12 am Purchase | 2022-12-30 | 13G | BIO-TECHNE CORP COM TECH | VANGUARD GROUP INC | 18,199,432 11.590% | 492,880 (+2.78%) | Filing History |
| 2023-01-26 08:52 am Unchanged | 2022-12-31 | 13G | BIO-TECHNE CORP COM TECH | BlackRock Inc. BLK | 15,888,640 10.100% | 0 (Unchanged) | Filing History |
| 2023-01-20 09:43 am Sale | 2022-12-31 | 13G | BIO-TECHNE CORP COM TECH | BlackRock Inc. BLK | 15,888,640 10.100% | -1,424,556 (-8.23%) | Filing History |
| 2022-02-09 3:33 pm Purchase | 2021-12-31 | 13G | BIO-TECHNE CORP COM TECH | VANGUARD GROUP INC | 17,706,552 11.270% | 444,380 (+2.57%) | Filing History |
| 2022-01-27 11:00 am Unchanged | 2021-12-31 | 13G | BIO-TECHNE CORP COM TECH | BlackRock Inc. BLK | 17,313,196 11.000% | 0 (Unchanged) | Filing History |
| 2022-01-25 3:03 pm Sale | 2021-12-31 | 13G | BIO-TECHNE CORP COM TECH | BlackRock Inc. BLK | 17,313,196 11.000% | -78,916 (-0.45%) | Filing History |
| 2021-09-10 09:42 am Purchase | 2021-08-31 | 13G | BIO-TECHNE CORP COM TECH | VANGUARD GROUP INC | 17,262,172 11.040% | 2,896,764 (+20.16%) | Filing History |